Harvard Bioscience, Inc. (HBIO)
7.48
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
-0.14
(-1.87%)
After-Hours: 20:00
Harvard Bioscience Debt to Equity Ratio : 5.959 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.959 |
| March 31, 2026 | 4.392 |
| December 31, 2025 | 3.224 |
| September 30, 2025 | 3.041 |
| June 30, 2025 | 2.753 |
| March 31, 2025 | 3.007 |
| December 31, 2024 | 0.7025 |
| September 30, 2024 | 0.6995 |
| June 30, 2024 | 0.6164 |
| March 31, 2024 | 0.6011 |
| December 31, 2023 | 0.5853 |
| September 30, 2023 | 0.6096 |
| June 30, 2023 | 0.6394 |
| March 31, 2023 | 0.6877 |
| December 31, 2022 | 0.7511 |
| September 30, 2022 | 0.7907 |
| June 30, 2022 | 0.7277 |
| March 31, 2022 | 0.7499 |
| December 31, 2021 | 0.683 |
| September 30, 2021 | 0.703 |
| June 30, 2021 | 0.6629 |
| March 31, 2021 | 0.6845 |
| December 31, 2020 | 0.7512 |
| September 30, 2020 | 0.6915 |
| June 30, 2020 | 0.7081 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7795 |
| December 31, 2019 | 0.7891 |
| September 30, 2019 | 0.8441 |
| June 30, 2019 | 0.8195 |
| March 31, 2019 | 0.8426 |
| December 31, 2018 | 0.7349 |
| September 30, 2018 | 0.754 |
| June 30, 2018 | 0.7979 |
| March 31, 2018 | 0.7943 |
| December 31, 2017 | 0.1452 |
| September 30, 2017 | 0.1617 |
| June 30, 2017 | 0.1755 |
| March 31, 2017 | 0.1878 |
| December 31, 2016 | 0.1904 |
| September 30, 2016 | 0.1982 |
| June 30, 2016 | 0.2108 |
| March 31, 2016 | 0.2193 |
| December 31, 2015 | 0.2436 |
| September 30, 2015 | 0.2137 |
| June 30, 2015 | 0.2178 |
| March 31, 2015 | 0.242 |
| December 31, 2014 | 0.2247 |
| September 30, 2014 | 0.2397 |
| June 30, 2014 | 0.2265 |
| March 31, 2014 | 0.2443 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.4711 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Danaher Corp. | 0.5298 |
| Illumina, Inc. | 0.8904 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 76.29M |
| Total Liabilities (Quarterly) | 68.87M |
| Shareholders Equity (Quarterly) | 7.418M |
| Current Ratio | 1.874 |
| Net Debt Paydown Yield | 0.29% |